BEAPHAR FLEA COLLAR FOR CATS
Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Summary of Product characteristics
(SPC)
07-12-2016
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
DIMPYLATE (AS STABILIZED DIAZINON AT 92% DIAZINON)
Available from:
Beaphar B.V.
ATC code:
QP53AF03
INN (International Name):
DIMPYLATE (AS STABILIZED DIAZINON AT 92% DIAZINON)
Dosage:
2.1 Grams
Pharmaceutical form:
Collar
Prescription type:
CAM-Companion Animal Medicine
Therapeutic group:
Feline
Therapeutic area:
Dimpylate
Therapeutic indications:
Ectoparasiticide
Authorization status:
Authorised
Authorization date:
2012-06-15
Summary of Product characteristics
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Beaphar Flea Collar for Cats
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
ONE COLLAR OF 35 CM LENGTH (14 G) CONTAINS:
ACTIVE SUBSTANCE:
Dimpylate (as stabilized diazinon at 92% diazinon) 2.1 g
EXCIPIENTS:
Erythrosine (E127)
0.042 g
For a full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Collar
Red, PVC collar.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cats
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of cats infested with fleas (_Ctenocephalides felis_)
4.3 CONTRAINDICATIONS
Do not use in case of hypersensitivity to the active substance, or to any of the excipients.
Do not use on sick and recovering cats.
Do not use in known cases of liver disorder.
Do not use on pregnant animals.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
When fitting, ensure that the collar is not too tight. Loosen the collar as the cat grows bigger.
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 22/11/2016_
_CRN 7024441_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTION(S) FOR USE IN ANIMALS
None.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS
Due to the potential risk of hypersensitivity developing in humans to dimpylate, unnecessary handling of this product
should be avoided.
4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
An intoxification typical for organophosphorus compounds occurs rarely. Rarely, local skin reaction at the site of collar
application may occur. Such reactions may be associated with either skin sensitivity to some of the substances in the collar
or an incorrectly fitted collar (too tight). If local skin
Read the complete document
